Researchers at the University of Edinburgh have used 3D printing technology to create artificial blood vessels.
These gel-like tubes, which closely resemble human veins, could revolutionize heart bypass surgery and improve patient outcomes worldwide.
This technology also paves the way for personalized medicine in cardiovascular care, allowing for custom-made artificial blood vessels for individual patients.
The artificial vessels are as strong as natural ones and flexible enough to integrate seamlessly into the human body.
They can be made in various sizes, from 1 to 40 mm in diameter, making them suitable for different vascular surgery applications.
Next, the researchers plan to test these artificial blood vessels in animal models. If successful, they will move on to human trials.
#science#Medical#3dprint#TechNews#3Dprinting#MedTwitter#Biotech
This could be a breakthrough for folks with multiple sclerosis. Propionic acid protects nerve cells and helps them regenerate – Patient Talk patienttalk.org/this-could-b…
As you kick off your #FallsPreventionAwarenessWeek action this week, use NCOA’s tools and resources on how to increase awareness around falls health and injury prevention—all conveniently gathered in one place for easy reference. #FPAW2022bit.ly/3TpOXQv
#MS#MultipleSclerosis#RRMS#PPMS#DMTs#MSmeds#FindACure There is NO EXISTING CURE for MS.With Disease Modifying Therapies (DMTs)we can try to slow the speed at which MS damages our brains and spinal cords.The $$$ to stay on meds($20,000-$30,000aMONTH)is unattainable for me!
Should you allow a "washout" when transitioning from an S1P Receptor modulator (gilenya, mayzent, zeposia) to a B Cell-Depleting drug (ocrevus, kesimpta, rituximab)? This observational study says a "washout" is unnecessary and increases risk. pubmed.ncbi.nlm.nih.gov/3558…
Extended interval tysabri? People taking Tysabri every 6 weeks (compared to every 4 weeks) had 4 times as many T2 hyperintense lesions on MRI after 72 weeks (0·20 (95% CI 0·07–0·63) in the once every 6 weeks group and 0·05 (0·01–0·22) in the once every 4 weeks group)
NEW ONLINE: the NOVA study investigators report results of a randomised trial comparing natalizumab once every 6 weeks with once every 4 weeks in patients with relapsing-remitting multiple sclerosis #MSAwarenessWEEKthelancet.com/journals/laneu…
ALT Progressive leukoencephalopathy scan. Credit: ZEPHYR/SCIENCE PHOTO LIBRARY
Some MS doctors argue for "deescalation," switching to less-effective drugs as people with MS get older to reduce risk. They argue oral drugs are just as good as infusibles for those ≥45 years. (authors include Dr. Brandi Vollmer and Dr. John Corboy) pubmed.ncbi.nlm.nih.gov/3514…
We had to buy a new van, I had to transfer in the old one and that time has come and gone. My lord, was that expensive! $35,000 for an 8 year old van. Ya think the companies that customize these vans make a good living? @jugheadsblog
#MS#MultipleSclerosis#RRMS#Gilenya So, abt a month ago I tripped&caught myself before a face plant.Hand/wrist injured and still hurt & now crack. Today my other hand is 3-finger #numb in that MS way. Takes me back to pre-dx 2005. Grateful this #symptom rarely pops up for me!